EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine

Generic: Acetaminophen, Aspirin, and Caffeine

Labeler: Lil' Drug Store Products, Inc.
NDC Directory HUMAN OTC DRUG NDA Inactive

Drug Facts

Product Profile

Brand Name EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine
Generic Name Acetaminophen, Aspirin, and Caffeine
Labeler Lil' Drug Store Products, Inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

ACETAMINOPHEN 250 mg/1, ASPIRIN 250 mg/1, CAFFEINE 65 mg/1

Identifiers & Regulatory

Product NDC 29485-8028
Product ID 29485-8028_00eccaeb-7718-7d22-e063-6294a90a8dd3
Product Type HUMAN OTC DRUG
Marketing Category NDA
Application Number NDA020802
Marketing Start 2010-02-15
Marketing End 2026-02-24

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 294858028
Hyphenated Format 29485-8028

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine (source: ndc)
Generic Name Acetaminophen, Aspirin, and Caffeine (source: ndc)
Application Number NDA020802 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 3 POUCH in 1 CARTON (29485-8028-6) / 2 TABLET, FILM COATED in 1 POUCH
source: ndc

Packages (1)

Ingredients (3)

ACETAMINOPHEN (250 mg/1) ASPIRIN (250 mg/1) CAFFEINE (65 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "00eccaeb-7718-7d22-e063-6294a90a8dd3", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["209468", "308297"], "spl_set_id": ["20406b7d-c989-40a5-b066-f3336c27a5fa"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Lil' Drug Store Products, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 POUCH in 1 CARTON (29485-8028-6)  / 2 TABLET, FILM COATED in 1 POUCH", "package_ndc": "29485-8028-6", "marketing_end_date": "20260224", "marketing_start_date": "20100215"}], "brand_name": "EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine", "product_id": "29485-8028_00eccaeb-7718-7d22-e063-6294a90a8dd3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "29485-8028", "generic_name": "Acetaminophen, Aspirin, and Caffeine", "labeler_name": "Lil' Drug Store Products, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "EXCEDRIN MIGRAINE acetaminophen, aspirin (nsaid) and caffeine", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "NDA020802", "marketing_category": "NDA", "marketing_end_date": "20260224", "marketing_start_date": "20100215"}